| Open | 393 |
| LTP | 384.05 |
| Previous Close | 384.05 |
| Day High | 398.25 |
| Day Low | 368 |
| Volume | 13566 |
| Code : | FERMENTA |
| Name : | Fermenta Biotech Ltd |
| Country : | India |
| Sector : | |
| Industry: |
| Market CAP : | 451 Cr |
| Stock P/E: | Not Available |
| ROCE: | -2081.61% |
| Book Value: | 0 |
| Dividend Yield : | 0% |
| Most Recent Quarter : | 2023-09-30 |
| Revenue/Sales TTM : | 0 |
| Operating Margin TTM : | 0% |
| Return On Equity TTM : | -20.82% |
| Profit Margin : | 0% |
| Market Capitalization : | 451 Cr |
| EBITDA : | Not Available |
| Book Value : | 0 |
| PERatio : | Not Available |
| Dividend Share : | |
| Earnings Share : | 0 |
| Gross Profit TTM : | 0 |
| Quarterly Earnings Growth YOY : | 0% |
| Dividend Yield : | % |
| Quarterly Revenue GrowthYOY : | 0 |
| Diluted Eps TTM : | 0 |
| Trailing PE : | 0 |
| Price Sales TTM : | 3.12 |
| Enter Prise Value : | 1,224 Cr |
| Enter Prise Value Ebidta : | 19.5596 |
| Forward PE : | 0 |
| Price Book MRQ : | 3.92 |
| Enter Prise Value Revenue : | 3.33 |
| Forward Annual Dividend Rate : | 0 |
| Payout Ratio : | 0 |
| Ex Dividend Date : | |
| Last Split Date : | 0000-00-00 |
| Forward Annual Dividend Yield : | 0 |
| Dividend Date : | |
| Last Split Factor : |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 398.87 | 413.68 | 429.12 | 383.43 | 368.62 | 353.18 | 338.37 |
| Fibonacci | 403.65 | 416.08 | 433.9 | 385.83 | 373.4 | 355.58 | 343.15 |
| Camarilla | 399.18 | 413.84 | 429.43 | 383.59 | 368.93 | 353.34 | 338.68 |
| Classic | 408.13 | 418.31 | 438.38 | 388.06 | 377.88 | 357.81 | 347.63 |
| Days 50 Day MA |
0 |
| Days 200 Day MA |
0 |
| Days 52 Week High |
440 |
| Days 52 Week Low |
145 |
| Quarterly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | EBIT | NetInterest Income | Income Tax Expense |
| Sep 2024 | 95 Cr | 82 Cr | 11 Cr | 0 | 4 Cr | 70 Lac | 0 | -4 Cr | 0 |
| Jun 2024 | 78 Cr | 83 Cr | -6 Cr | 0 | 3 Cr | 0 | 0 | -3 Cr | 0 |
| Mar 2024 | 95 Cr | 90 Cr | -7 Cr | 0 | 2 Cr | 8 Cr | 0 | 0 Cr | 0 |
| Dec 2023 | 99 Cr | 80 Cr | 10 Cr | 0 | 5 Cr | 6 Cr | 0 | -5 Cr | 0 |
| Yearly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | Interest Income | Net Interest Income | Income Tax Expense |
| Dec 2023 | 333 Cr | 324 Cr | -23 Cr | 0 | 16 Cr | 14 Cr | 4 Cr | -14 Cr | 0 |
| Dec 2022 | 350 Cr | 350 Cr | -51 Cr | 0 | 3 Cr | 2 Cr | 17 Cr | -19 Cr | 0 |
| Dec 2021 | 399 Cr | 359 Cr | 15 Cr | 0 | 3 Cr | 12 Cr | 14 Cr | -17 Cr | 0 |
| Dec 2020 | 377 Cr | 305 Cr | 46 Cr | 0 | 3 Cr | 9 Cr | 10 Cr | -15 Cr | 0 |
| Quarterly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Sep 2024 | 539 Cr | 244 Cr | 101 Cr | 253 Cr | 0 | 184 Cr | 290 Cr |
| Mar 2024 | 548 Cr | 242 Cr | 87 Cr | 263 Cr | 0 | 173 Cr | 289 Cr |
| Sep 2023 | 595 Cr | 239 Cr | 108 Cr | 308 Cr | 0 | 224 Cr | 287 Cr |
| Mar 2023 | 636 Cr | 253 Cr | 130 Cr | 321 Cr | 0 | 209 Cr | 315 Cr |
| Yearly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Dec 2023 | 548 Cr | 242 Cr | 87 Cr | 263 Cr | 0 | 173 Cr | 289 Cr |
| Dec 2022 | 636 Cr | 253 Cr | 130 Cr | 321 Cr | 0 | 209 Cr | 315 Cr |
| Dec 2021 | 707 Cr | 314 Cr | 159 Cr | 335 Cr | 0 | 207 Cr | 372 Cr |
| Dec 2020 | 687 Cr | 310 Cr | 162 Cr | 326 Cr | 0 | 209 Cr | 361 Cr |
| Quarterly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Sep 2024 | 0 | 0 | 0 | 0 | 11 Cr | 0 | 0 |
| Jun 2024 | 0 | 0 | 0 | 0 | -6 Cr | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 | 0 | -7 Cr | 0 | 0 |
| Dec 2023 | 0 | 0 | 0 | 0 | 10 Cr | 0 | 0 |
| Yearly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Dec 2023 | 0 | 4 Cr | 43 Cr | -15 Cr | -23 Cr | 25 Cr | 19 Cr |
| Dec 2022 | 0 | 4 Cr | 10 Cr | -55 Cr | -52 Cr | 28 Cr | 40 Cr |
| Dec 2021 | 0 | 7 Cr | 3 Cr | -26 Cr | 27 Cr | 26 Cr | 37 Cr |
| Dec 2020 | 0 | 0 | -19 Cr | -42 Cr | 52 Cr | 20 Cr | 55 Cr |
| Date | Target 3 | Target 2 | Target 1 | Trading Levels | Target 1 | Target 2 | Target 3 | |
|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 248.35 | 249.00 | 249.85 | 250.90 |
251.90 |
252.95 | 253.80 | 254.45 |
| Open | 393 |
| LTP | 384.05 |
| Previous Close | 384.05 |
| Day High | 398.25 |
| Day Low | 368 |
| Volume | 13566 |
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Lloyds Steels Industries Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GMR Infrastructure Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3i Infotech Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Company WIPRO |
LTP 309.1 |
Change 10.75 |
Gain 3.6 % |
|
Company TCS |
LTP 4156.6 |
Change 120.75 |
Gain 2.99 % |
|
Company BAJAJFINSV |
LTP 1743.3 |
Change 26.3 |
Gain 1.53 % |
|
Company BAJFINANCE |
LTP 7397.15 |
Change 105.5 |
Gain 1.45 % |
|
Company HDFCBANK |
LTP 1666.05 |
Change 23.65 |
Gain 1.44 % |
|
Company TATAMOTORS |
LTP 742.75 |
Change -18 |
Loss -18 % |
|
Company AXISBANK |
LTP 959.3 |
Change -10.9 |
Loss -10.9 % |
|
Company BPCL |
LTP 277.6 |
Change -2.6 |
Loss -2.6 % |
|
Company SBIN |
LTP 753.45 |
Change -5.6 |
Loss -5.6 % |
|
Company ONGC |
LTP 264.05 |
Change -1.75 |
Loss -1.75 % |
Motilal Oswal's research report on Dixon TechnologiesDixon Technologies (Dixon) reported better-than-expected revenue and EBITDA, driven by strong performance of the mobile and EMS segment, while PAT stood lower than our estimates on higher depreciation, interest, and minority interest. The company’s revenue/EBITDA jumped 117%/112% YoY for 3QFY25. The mobile and EMS segment continues to benefit ...
Shares of Multi Commodity Exchange of India (MCX) crashed 10 percent on January 21. This comes after brokerage Morgan Stanley issued an 'underweight' call for the stock, stating that the firm's Q3 net profit has fallen below its estimate.At 11:20 am on January 21, MCX shares were trading nearly 11% lower at Rs 5,388 apiece.MCX had released its quarterly results for October-December in the post-mar...
Shares of Mankind Pharma slipped 4 percent to Rs 2,606, snapping its two-day gaining streak on the bourses on January 21 after Macquarie downgraded Mankind Pharma to "Underperform" with a target price of Rs 2,150, reflecting a 7 percent downside from the previous close.The international brokerage said that the domestic formulations business remains weak, driven by slower growth in acute therapies,...
The Q3 earnings season kicked off right in the middle of market chaos—caught between pre-budget buzz, US policy jitters, India’s faltering growth, and sky-high valuations. January, already cursed with weak seasonality, has been a rollercoaster of volatility, leaving investors in a pool of caution.One standout trend this season? Investors are getting seriously choosy. This marks a stark differe...
Sellwin Traders, which reported a 90 percent jump in income for the December quarter, on Sunday said it has signed a pact with UAE-based Secorbit FZCO for developing a blockchain-based tokenization platform for equities, bonds, and real-world assets for USD 3 million (around Rs 26 crore).The platform will be developed for Secorbit to “enable the tokenization of equities, bonds, and real-world as...
